Organometallic Compounds for OLED Brightness and Diagnostic Sensitivity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing organic light-emitting devices face challenges in enhancing performance characteristics such as viewing angles, response time, brightness, and driving voltages, while luminescent compounds used for biological sensing and detection lack specificity and sensitivity.

Innovation Solution

The development of organometallic compounds represented by Formula 1, which can be incorporated into organic light-emitting devices to improve performance and used in diagnostic compositions for sensitive biological detection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional organic light-emitting devices are used, then basic light emission function is achieved, but performance characteristics such as viewing angles, response time, brightness, and driving voltages cannot be enhanced

Engineering Contradiction:
Improveperformance characteristicsVSAvoidperformance enhancement capability
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent applies parameter changes by modifying the molecular structure of organometallic compounds through varying ligand types (carbene, phosphine, N-heterocyclic carbene), metal centers (Ir, Pt, Os), and substituent groups. These structural parameter changes result in improved photophysical properties including enhanced quantum efficiency, adjusted emission wavelengths, and optimized electroluminescence characteristics, thereby enhancing overall device performance

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If luminescent compounds are used for biological sensing, then detection function is achieved, but specificity and sensitivity are insufficient

Engineering Contradiction:
Improvedetection sensitivityVSAvoiddetection specificity
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent applies local quality by introducing specific functional groups and moieties at particular positions within the organometallic compound structure. For example, incorporating biorecognition elements such as aptamers, antibodies, or specific ligand groups at designated locations enables selective binding to target analytes, thereby enhancing both sensitivity and specificity for biological detection applications

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The organometallic compounds enhance the performance of organic light-emitting devices by improving viewing angles, response time, and brightness, and provide sensitive diagnostic tools for biological materials.

Implementation Method 1

These excitons transit from an excited state to a ground state, thereby generating light

Methodology Applied
Scientific EffectElectroluminescence: Electroluminescence

Implementation Method 2

luminescent compounds, for example, phosphorescent compounds, may be used for monitoring, sensing, and detecting biological materials such as various cells and proteins

Methodology Applied
Scientific EffectPhosphorescence: Phosphorescence

Data Source

PatentUS12415826B2Organometallic compound, organic light-emitting device including the same, and diagnostic composition for including the organometallic compound
Publication Date: 2025.09.16 SAMSUNG ELECTRONICS CO LTD
  • US12415826B2 patent drawing
  • US12415826B2 patent drawing
  • US12415826B2 patent drawing

AI summary

Provided are an organometallic compound of Formula 1, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound.In Formula 1, ring A1, ring A3, and ring A4 are each independently a C5-C30 carbocyclic group or a C2-C60 heterocyclic group, and ring A2 is an N-containing 5-membered heterocyclic group.